JP2009522579A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009522579A5 JP2009522579A5 JP2008549576A JP2008549576A JP2009522579A5 JP 2009522579 A5 JP2009522579 A5 JP 2009522579A5 JP 2008549576 A JP2008549576 A JP 2008549576A JP 2008549576 A JP2008549576 A JP 2008549576A JP 2009522579 A5 JP2009522579 A5 JP 2009522579A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- cell
- orai
- test agent
- nfat regulatory
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229920001184 polypeptide Polymers 0.000 claims 45
- 102000004196 processed proteins & peptides Human genes 0.000 claims 45
- 108090000765 processed proteins & peptides Proteins 0.000 claims 45
- 210000004027 cell Anatomy 0.000 claims 44
- 238000000034 method Methods 0.000 claims 34
- 239000003795 chemical substances by application Substances 0.000 claims 28
- 101100114828 Drosophila melanogaster Orai gene Proteins 0.000 claims 23
- 230000001105 regulatory effect Effects 0.000 claims 18
- 230000000694 effects Effects 0.000 claims 9
- 102000034356 gene-regulatory proteins Human genes 0.000 claims 8
- 108091006104 gene-regulatory proteins Proteins 0.000 claims 8
- 102100039319 Calcium release-activated calcium channel protein 1 Human genes 0.000 claims 7
- 101001122471 Homo sapiens Protein orai-3 Proteins 0.000 claims 7
- 108700027851 ORAI1 Proteins 0.000 claims 7
- 102000049665 ORAI2 Human genes 0.000 claims 7
- 108700027852 ORAI2 Proteins 0.000 claims 7
- 101150002636 ORAI2 gene Proteins 0.000 claims 7
- 102100027135 Protein orai-3 Human genes 0.000 claims 7
- 150000001768 cations Chemical class 0.000 claims 7
- 230000004941 influx Effects 0.000 claims 7
- 101150060735 orai1 gene Proteins 0.000 claims 7
- 101150079867 Orai gene Proteins 0.000 claims 6
- 108700005075 Regulator Genes Proteins 0.000 claims 6
- 230000027455 binding Effects 0.000 claims 6
- 102000039446 nucleic acids Human genes 0.000 claims 6
- 108020004707 nucleic acids Proteins 0.000 claims 6
- 150000007523 nucleic acids Chemical class 0.000 claims 6
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims 5
- 108091006146 Channels Proteins 0.000 claims 5
- 229910052791 calcium Inorganic materials 0.000 claims 5
- 239000011575 calcium Substances 0.000 claims 5
- 230000014509 gene expression Effects 0.000 claims 5
- 238000012216 screening Methods 0.000 claims 5
- 241000238631 Hexapoda Species 0.000 claims 4
- 241000283984 Rodentia Species 0.000 claims 4
- 101150101888 Stim gene Proteins 0.000 claims 4
- 241000269370 Xenopus <genus> Species 0.000 claims 4
- 210000005260 human cell Anatomy 0.000 claims 4
- 210000004962 mammalian cell Anatomy 0.000 claims 4
- 101100043696 Drosophila melanogaster Stim gene Proteins 0.000 claims 3
- 230000009460 calcium influx Effects 0.000 claims 3
- 230000001413 cellular effect Effects 0.000 claims 3
- 230000004907 flux Effects 0.000 claims 3
- 239000012634 fragment Substances 0.000 claims 3
- 210000000170 cell membrane Anatomy 0.000 claims 2
- 230000003993 interaction Effects 0.000 claims 2
- 150000002500 ions Chemical class 0.000 claims 2
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 1
- 239000013543 active substance Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US75693406P | 2006-01-05 | 2006-01-05 | |
| US60/756,934 | 2006-01-05 | ||
| PCT/US2007/000280 WO2007081804A2 (en) | 2006-01-05 | 2007-01-05 | Regulators of nfat |
Related Child Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013268702A Division JP2014128267A (ja) | 2006-01-05 | 2013-12-26 | Nfatの制御因子 |
| JP2014000164A Division JP6025758B2 (ja) | 2006-01-05 | 2014-01-06 | Nfatの制御因子 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009522579A JP2009522579A (ja) | 2009-06-11 |
| JP2009522579A5 true JP2009522579A5 (enExample) | 2010-06-24 |
| JP5881270B2 JP5881270B2 (ja) | 2016-03-09 |
Family
ID=38256924
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008549576A Active JP5881270B2 (ja) | 2006-01-05 | 2007-01-05 | Nfatの制御因子 |
| JP2013268702A Withdrawn JP2014128267A (ja) | 2006-01-05 | 2013-12-26 | Nfatの制御因子 |
| JP2014000164A Active JP6025758B2 (ja) | 2006-01-05 | 2014-01-06 | Nfatの制御因子 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013268702A Withdrawn JP2014128267A (ja) | 2006-01-05 | 2013-12-26 | Nfatの制御因子 |
| JP2014000164A Active JP6025758B2 (ja) | 2006-01-05 | 2014-01-06 | Nfatの制御因子 |
Country Status (5)
| Country | Link |
|---|---|
| US (4) | US8399185B2 (enExample) |
| EP (2) | EP1984400B1 (enExample) |
| JP (3) | JP5881270B2 (enExample) |
| CA (1) | CA2636417C (enExample) |
| WO (1) | WO2007081804A2 (enExample) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1984400B1 (en) | 2006-01-05 | 2012-11-28 | Immune Disease Institute, Inc. | Regulators of nfat |
| EP2013627A4 (en) * | 2006-04-10 | 2009-08-05 | Queens Medical Ct | CRAC-MODULATORS AND ITS USE IN THE ACTIVE SUBSTANCE |
| WO2007139926A2 (en) * | 2006-05-26 | 2007-12-06 | The Regents Of The University Of California | Crac channel and modulator screening methods |
| WO2008148108A1 (en) | 2007-05-24 | 2008-12-04 | Calcimedica, Inc. | Calcium channel proteins and uses thereof |
| CA2699157A1 (en) | 2007-09-10 | 2009-03-19 | Calcimedica, Inc. | Compounds that modulate intracellular calcium |
| GB0800938D0 (en) * | 2008-01-18 | 2008-02-27 | Ge Healthcare Uk Ltd | Multiplex cell signalling assay |
| EP2321303B1 (en) | 2008-08-27 | 2019-11-27 | Calcimedica, Inc. | Compounds that modulate intracellular calcium |
| US8394778B1 (en) | 2009-10-08 | 2013-03-12 | Immune Disease Institute, Inc. | Regulators of NFAT and/or store-operated calcium entry |
| TW201129379A (en) | 2009-11-20 | 2011-09-01 | Amgen Inc | Anti-Orai1 antigen binding proteins and uses thereof |
| WO2012144972A2 (en) * | 2010-01-19 | 2012-10-26 | The General Hospital Corporation | Methods to inhibit neurodegeneration |
| EP2563759B1 (en) | 2010-04-27 | 2022-04-06 | Calcimedica, Inc. | Compounds that modulate intracellular calcium |
| US10703722B2 (en) | 2010-04-27 | 2020-07-07 | Calcimedica, Inc. | Compounds that modulate intracellular calcium |
| PT2563776T (pt) | 2010-04-27 | 2016-09-19 | Calcimedica Inc | Compostos que modulam o cálcio intracelular |
| KR101204620B1 (ko) | 2010-08-06 | 2012-11-27 | 가톨릭대학교 산학협력단 | 혈관 형성 관련 질환 진단용 마커 및 이의 용도 |
| CA2809830C (en) | 2010-08-27 | 2019-09-10 | Calcimedica, Inc. | Compounds comprising n-acyl-2-amino-1,3-thiazole for modulating intracellular calcium |
| US9567580B2 (en) | 2010-10-08 | 2017-02-14 | Anjana Rao | Regulators of NFAT and/or store-operated calcium entry |
| US20140294873A1 (en) * | 2011-11-08 | 2014-10-02 | Children Medical Center Corporation | Small molecule screen for inhibitors of nfat: ap-1: dna interactions |
| US9512116B2 (en) | 2012-10-12 | 2016-12-06 | Calcimedica, Inc. | Compounds that modulate intracellular calcium |
| US9611263B2 (en) | 2013-10-08 | 2017-04-04 | Calcimedica, Inc. | Compounds that modulate intracellular calcium |
| WO2015196068A2 (en) * | 2014-06-20 | 2015-12-23 | Geisinger Clinic | Loss of dyrk1b gene function to inhibit metabolic syndrome including diabetes and hypertension |
| RS61588B1 (sr) | 2014-08-07 | 2021-04-29 | Daiichi Sankyo Co Ltd | Anti-orai1 antitelo |
| JP6366415B2 (ja) * | 2014-08-07 | 2018-08-01 | 株式会社 資生堂 | Orai3遺伝子発現抑制剤又はORAI3タンパク質の機能抑制剤を含む細胞賦活剤 |
| EP3778595B1 (en) | 2015-02-27 | 2021-08-25 | Calcimedica, Inc. | Pancreatitis treatment |
| EP3331525B1 (en) | 2015-08-07 | 2020-10-07 | Calcimedica, Inc. | Use of crac channel inhibitors for the treatment of stroke and traumatic brain injury |
| KR20200071082A (ko) | 2017-10-17 | 2020-06-18 | 리젠 파마슈티컬스 소시에떼 아노님 | 식도암을 치료하기 위한 crac 채널 조절제 |
| WO2019082124A1 (en) | 2017-10-26 | 2019-05-02 | Rhizen Pharmaceuticals Sa | COMPOSITION AND METHOD FOR THE TREATMENT OF LARGE B-CELL DIFFUSED LYMPHOMA |
| BR112020008219A2 (pt) | 2017-10-30 | 2020-10-27 | Rhizen Pharmaceuticals Sa | moduladores de canal de cálcio ativado por liberação de cálcio para tratar cânceres hematológicos e sólidos |
| MX2021003094A (es) | 2018-09-14 | 2021-05-12 | Rhizen Pharmaceuticals A G | Composiciones que comprenden un inhibidor de crac y un corticosteroide y métodos de uso de estas. |
| WO2020141106A1 (en) * | 2019-01-03 | 2020-07-09 | Kemijski Institut | Engineered externally regulated artificial transcription regulatory system based on engineered nfat |
| JP2023526505A (ja) | 2020-05-20 | 2023-06-21 | カルシメディカ,インク. | 急性腎障害を治療するための方法および組成物 |
| US12522589B2 (en) | 2020-11-13 | 2026-01-13 | Calcimedica, Inc. | Synthesis of CRAC channel inhibitors |
| CN112458149B (zh) * | 2020-12-03 | 2021-10-08 | 北京东方百泰生物科技股份有限公司 | 一种以cd3为靶点的抗体药物对t细胞激活程度的检测方法 |
Family Cites Families (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4109496A (en) | 1977-12-20 | 1978-08-29 | Norris Industries | Trapped key mechanism |
| US4868103A (en) | 1986-02-19 | 1989-09-19 | Enzo Biochem, Inc. | Analyte detection by means of energy transfer |
| US5080891A (en) | 1987-08-03 | 1992-01-14 | Ddi Pharmaceuticals, Inc. | Conjugates of superoxide dismutase coupled to high molecular weight polyalkylene glycols |
| US5223409A (en) | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
| EP0552108B1 (en) | 1992-01-17 | 1999-11-10 | Lakowicz, Joseph R. | Energy transfer phase-modulation fluoro-immunoassay |
| CA2148252C (en) | 1992-10-30 | 2007-06-12 | Roger Brent | Interaction trap system for isolating novel proteins |
| US20040002117A1 (en) | 1998-02-12 | 2004-01-01 | Hogan Patrick G. | Specific inhibitors of NFAT activation by calcineurin and their use in treating immune-related diseases |
| EP0976823A1 (de) | 1998-07-22 | 2000-02-02 | Helge Dr. Völkel | Rekombinantes Expressions System und Hoch-Durchsatz BioAssay für die therapeutische Anwendung von Calcineurin-A-Alpha, Calcineurin-A-Beta, Calcineurin-A-Gamma, Calcineurin-B und Copper/Zinc-Superoxide Dismutase bzw. zur Identifizierung von Pharmazeutika |
| EP1074617A3 (en) * | 1999-07-29 | 2004-04-21 | Research Association for Biotechnology | Primers for synthesising full-length cDNA and their use |
| US6485924B2 (en) | 1999-12-07 | 2002-11-26 | Boehringer Ingelheim International Gmbh | Method for identifying inhibitors of cytokinesis |
| US20040219521A1 (en) | 2000-01-21 | 2004-11-04 | Tang Y. Tom | Novel nucleic acids and polypeptides |
| CN1177864C (zh) | 2000-06-20 | 2004-12-01 | 上海市肿瘤研究所 | 在肝癌组织中具有表达差异的新的人蛋白及其编码序列 |
| WO2002030976A1 (en) | 2000-10-11 | 2002-04-18 | The University Of Melbourne | Cell control nucleic acids and proteins |
| US6783969B1 (en) * | 2001-03-05 | 2004-08-31 | Nuvelo, Inc. | Cathepsin V-like polypeptides |
| WO2003052049A2 (en) | 2001-07-09 | 2003-06-26 | Incyte Genomics, Inc. | Molecules for disease detection and treatment |
| NZ513755A (en) | 2001-08-24 | 2001-09-28 | Ann Rachel Holmes | Protein expression system in yeast comprising a vector encoding a heterologous membrane protein and its application in screening for drugs |
| EP1293569A3 (en) | 2001-09-14 | 2004-03-31 | Research Association for Biotechnology | Full-length cDNAs |
| US20050107588A1 (en) * | 2001-11-13 | 2005-05-19 | Duggan Brendan M. | Receptors and membrane-associated proteins |
| JP2006507841A (ja) | 2002-11-14 | 2006-03-09 | ダーマコン, インコーポレイテッド | 機能的siRNAおよび超機能的siRNA |
| WO2004078995A2 (en) * | 2003-03-04 | 2004-09-16 | Neurogenetics, Inc. | Methods of modulating and of identifying agents that modulate intracellular calcium |
| WO2005019258A2 (en) | 2003-08-11 | 2005-03-03 | Genentech, Inc. | Compositions and methods for the treatment of immune related diseases |
| JP2008518610A (ja) | 2004-11-03 | 2008-06-05 | アルマック ダイアグノスティックス リミテッド | トランスクリプトームマイクロアレイ技法およびそれを使用する方法 |
| CA2606341A1 (en) | 2005-04-29 | 2006-11-09 | Genizon Biosciences Inc. | Genemap of the human genes associated with crohn's disease |
| US7481994B2 (en) | 2005-06-07 | 2009-01-27 | The Board Of Trustees Of The Leland Stanford Junior University | Calcium biosensor polypeptides and methods of use |
| WO2007047796A2 (en) | 2005-10-17 | 2007-04-26 | Institute For Systems Biology | Tissue-and serum-derived glycoproteins and methods of their use |
| EP1984400B1 (en) | 2006-01-05 | 2012-11-28 | Immune Disease Institute, Inc. | Regulators of nfat |
| EP2013627A4 (en) | 2006-04-10 | 2009-08-05 | Queens Medical Ct | CRAC-MODULATORS AND ITS USE IN THE ACTIVE SUBSTANCE |
| WO2007139926A2 (en) | 2006-05-26 | 2007-12-06 | The Regents Of The University Of California | Crac channel and modulator screening methods |
| WO2008148108A1 (en) | 2007-05-24 | 2008-12-04 | Calcimedica, Inc. | Calcium channel proteins and uses thereof |
| JP5559049B2 (ja) | 2007-07-10 | 2014-07-23 | チルドレンズ メディカル センター コーポレーション | 間質相互作用分子ノックアウトマウス及びその使用 |
| US20090074750A1 (en) | 2007-09-18 | 2009-03-19 | Onn Brandman | Regulator of basal cellular calcium concentration and methods of use |
| JP2011515376A (ja) | 2008-03-20 | 2011-05-19 | ツェー・エス・エル・ベーリング・ゲー・エム・ベー・ハー | 病的血栓形成に必須であるカルシウムセンサSTIM1及び血小板SOCチャネルOrai1(CRACM1) |
| US20120165265A1 (en) | 2009-02-26 | 2012-06-28 | Dolmetsch Ricardo E | Calcium Signaling Modulators Involving STIM and ORAI Proteins |
-
2007
- 2007-01-05 EP EP07717846A patent/EP1984400B1/en active Active
- 2007-01-05 US US12/160,030 patent/US8399185B2/en active Active
- 2007-01-05 JP JP2008549576A patent/JP5881270B2/ja active Active
- 2007-01-05 EP EP10191986.8A patent/EP2368912B1/en active Active
- 2007-01-05 CA CA2636417A patent/CA2636417C/en active Active
- 2007-01-05 WO PCT/US2007/000280 patent/WO2007081804A2/en not_active Ceased
-
2011
- 2011-06-15 US US13/161,307 patent/US9163078B2/en active Active
-
2013
- 2013-12-26 JP JP2013268702A patent/JP2014128267A/ja not_active Withdrawn
-
2014
- 2014-01-06 JP JP2014000164A patent/JP6025758B2/ja active Active
-
2015
- 2015-08-21 US US14/832,922 patent/US9932378B2/en active Active
-
2018
- 2018-02-20 US US15/900,698 patent/US20180194821A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009522579A5 (enExample) | ||
| RU2016102922A (ru) | Способы идентификации, изоляции и применения рецепторов пахучих веществ и ароматов | |
| Goodman et al. | How Caenorhabditis elegans senses mechanical stress, temperature, and other physical stimuli | |
| MY153980A (en) | Method for identifying allergenic proteins and peptides | |
| Watanabe et al. | Type XVII collagen coordinates proliferation in the interfollicular epidermis | |
| Van den Bos et al. | Phosphorylation of MRP14, an S100 protein expressed during monocytic differentiation, modulates Ca (2+)-dependent translocation from cytoplasm to membranes and cytoskeleton | |
| BRPI0618391A2 (pt) | método para identificar um nucleotìdeo individual, método para seqüenciar uma seqüência de ácido nucleico alvo, e, kit para seqüenciar um ácido nucleico | |
| RU2009129185A (ru) | Способы и мишени для идентификации соединений для регуляции риновирусной инфекции | |
| CA2483961A1 (en) | Methods of screening for trpm4b modulators | |
| DK1495330T3 (da) | Fremgangsmåde til at identificere forbindelser, som påvirker transmembran-proteiner | |
| JP2006519020A5 (enExample) | ||
| CL2007003785A1 (es) | Acidos nucleicos aislados de bacillus thuringensis, construccion y celulas huesped que comprenden dichos acidos nucleicos, polipeptidos aislados con actividad pesticida codificados por estos polinucleoticos, metodo de produccion de dichas proteinas con actividad pesticida, y para controlar una plaga de insectos. | |
| WO2006138433A3 (en) | Induction of cell differentiation by class i bhlh polypeptides | |
| JP2017528120A5 (enExample) | ||
| DE60233147D1 (de) | Verwendung von hmgb1 zur aktivierung dendritischer zellen | |
| JP2009533065A5 (enExample) | ||
| JP2009539377A5 (enExample) | ||
| DE602007004143D1 (de) | Verfahren zur Beurteilung der Lebensfähigkeit von Embryos | |
| AU2008232699A8 (en) | High expression clones of mammalian cells with fluorescent protein A or G | |
| WO2009141352A3 (en) | Risk analysis in patients with and without metabolic syndrome | |
| JP2006526389A5 (enExample) | ||
| JP2005535289A5 (enExample) | ||
| WO2008147206A3 (en) | Means and methods for classifying samples of multiple sclerosis patients | |
| WO2005035713A3 (en) | Alternatively spliced variants of human cox1 | |
| WO2007138066A3 (en) | Method of screening for compounds that alter skin and/or hair pigmentation |